140 related articles for article (PubMed ID: 32694701)
21. The tumour microenvironment of the upper and lower gastrointestinal tract differentially influences dendritic cell maturation.
Morrissey ME; Byrne R; Nulty C; McCabe NH; Lynam-Lennon N; Butler CT; Kennedy S; O'Toole D; Larkin J; McCormick P; Mehigan B; Cathcart MC; Lysaght J; Reynolds JV; Ryan EJ; Dunne MR; O'Sullivan J
BMC Cancer; 2020 Jun; 20(1):566. PubMed ID: 32552799
[TBL] [Abstract][Full Text] [Related]
22. Visceral adipose tissue secretome from early and late-stage oesophageal cancer patients differentially affects effector and regulatory T cells.
Davern M; Bracken-Clarke D; Donlon NE; Sheppard AD; Connell FO; Heeran AB; Majcher K; Conroy MJ; Mylod E; Butler C; Donohoe C; Donnell DO; Lowery M; Bhardwaj A; Ravi N; Melo AA; Sullivan JO; Reynolds JV; Lysaght J
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6583-6599. PubMed ID: 36790524
[TBL] [Abstract][Full Text] [Related]
23. Leptin stimulates the proliferation of human oesophageal adenocarcinoma cells via HB-EGF and Tgfalpha mediated transactivation of the epidermal growth factor receptor.
Ogunwobi OO; Beales IL
Br J Biomed Sci; 2008; 65(3):121-7. PubMed ID: 18986098
[TBL] [Abstract][Full Text] [Related]
24. Dynamic bioenergetic alterations in colorectal adenomatous polyps and adenocarcinomas.
Lin WR; Chiang JM; Lim SN; Su MY; Chen TH; Huang SW; Chen CW; Wu RC; Tsai CL; Lin YH; Alison MR; Hsieh SY; Yu JS; Chiu CT; Yeh CT
EBioMedicine; 2019 Jun; 44():334-345. PubMed ID: 31122841
[TBL] [Abstract][Full Text] [Related]
25. Clinical response to chemotherapy in oesophageal adenocarcinoma patients is linked to defects in mitochondria.
Aichler M; Elsner M; Ludyga N; Feuchtinger A; Zangen V; Maier SK; Balluff B; Schöne C; Hierber L; Braselmann H; Meding S; Rauser S; Zischka H; Aubele M; Schmitt M; Feith M; Hauck SM; Ueffing M; Langer R; Kuster B; Zitzelsberger H; Höfler H; Walch AK
J Pathol; 2013 Aug; 230(4):410-9. PubMed ID: 23592244
[TBL] [Abstract][Full Text] [Related]
26. Impact of the inflammatory microenvironment on T-cell phenotype in the progression from reflux oesophagitis to Barrett oesophagus and oesophageal adenocarcinoma.
Kavanagh ME; Conroy MJ; Clarke NE; Gilmartin NT; O'Sullivan KE; Feighery R; MacCarthy F; O'Toole D; Ravi N; Reynolds JV; O'Sullivan J; Lysaght J
Cancer Lett; 2016 Jan; 370(1):117-24. PubMed ID: 26519754
[TBL] [Abstract][Full Text] [Related]
27. DNA epigenetic signature predictive of benefit from neoadjuvant chemotherapy in oesophageal adenocarcinoma: results from the MRC OE02 trial.
Sundar R; Ng A; Zouridis H; Padmanabhan N; Sheng T; Zhang S; Lee MH; Ooi WF; Qamra A; Inam I; Hewitt LC; So JB; Koh V; Nankivell MG; Langley RE; Allum WH; Cunningham D; Rozen SG; Yong WP; Grabsch HI; Tan P
Eur J Cancer; 2019 Dec; 123():48-57. PubMed ID: 31655359
[TBL] [Abstract][Full Text] [Related]
28. Characterisation of an Isogenic Model of Cisplatin Resistance in Oesophageal Adenocarcinoma Cells.
Buckley AM; Bibby BA; Dunne MR; Kennedy SA; Davern MB; Kennedy BN; Maher SG; O'Sullivan J
Pharmaceuticals (Basel); 2019 Feb; 12(1):. PubMed ID: 30791601
[TBL] [Abstract][Full Text] [Related]
29. Design of a multi-sensor platform for integrating extracellular acidification rate with multi-metabolite flux measurement for small biological samples.
Obeidat YM; Cheng MH; Catandi G; Carnevale E; Chicco AJ; Chen TW
Biosens Bioelectron; 2019 May; 133():39-47. PubMed ID: 30909011
[TBL] [Abstract][Full Text] [Related]
30. Neutrophil to lymphocyte ratio as a predictor of response to neoadjuvant chemotherapy and survival in oesophageal adenocarcinoma.
Powell AGMT; Chin C; Coxon AH; Chalishazar A; Christian A; Roberts SA; Lewis WG
BJS Open; 2020 Jun; 4(3):416-423. PubMed ID: 32232963
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA Profiling in Oesophageal Adenocarcinoma Cell Lines and Patient Serum Samples Reveals a Role for miR-451a in Radiation Resistance.
Butz F; Eichelmann AK; Mayne GC; Wang T; Bastian I; Chiam K; Marri S; Sykes PJ; Wijnhoven BP; Toxopeus E; Michael MZ; Karapetis CS; Hummel R; Watson DI; Hussey DJ
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255413
[TBL] [Abstract][Full Text] [Related]
32. PI3K inhibition as a novel therapeutic strategy for neoadjuvant chemoradiotherapy resistant oesophageal adenocarcinoma.
Edge SD; Renard I; Pyne E; Li C; Moody H; Roy R; Beavis AW; Archibald SJ; Cawthorne CJ; Maher SG; Pires IM
Br J Radiol; 2021 Mar; 94(1119):20201191. PubMed ID: 33434085
[TBL] [Abstract][Full Text] [Related]
33. Evaluating the Role of RARβ Signaling on Cellular Metabolism in Melanoma Using the Seahorse XF Analyzer.
Dahl C; Guldberg P; Abildgaard C
Methods Mol Biol; 2019; 2019():171-180. PubMed ID: 31359396
[TBL] [Abstract][Full Text] [Related]
34. Secreted human adipose leptin decreases mitochondrial respiration in HCT116 colon cancer cells.
Yehuda-Shnaidman E; Nimri L; Tarnovscki T; Kirshtein B; Rudich A; Schwartz B
PLoS One; 2013; 8(9):e74843. PubMed ID: 24073224
[TBL] [Abstract][Full Text] [Related]
35. Tumour microenvironment influences response to treatment in oesophageal adenocarcinoma.
Belle CJ; Lonie JM; Brosda S; Barbour AP
Front Immunol; 2023; 14():1330635. PubMed ID: 38155973
[TBL] [Abstract][Full Text] [Related]
36. Globular adiponectin, acting via adiponectin receptor-1, inhibits leptin-stimulated oesophageal adenocarcinoma cell proliferation.
Ogunwobi OO; Beales IL
Mol Cell Endocrinol; 2008 Mar; 285(1-2):43-50. PubMed ID: 18313838
[TBL] [Abstract][Full Text] [Related]
37. Individual patient oesophageal cancer 3D models for tailored treatment.
Saunders JH; Onion D; Collier P; Dorrington MS; Argent RH; Clarke PA; Reece-Smith AM; Parsons SL; Grabowska AM
Oncotarget; 2017 Apr; 8(15):24224-24236. PubMed ID: 27736801
[TBL] [Abstract][Full Text] [Related]
38. Impact of Deoxycholic Acid on Oesophageal Adenocarcinoma Invasion: Effect on Matrix Metalloproteinases.
Quilty F; Byrne AM; Aird J; El Mashad S; Parra-Blanco A; Long A; Gilmer JF; Medina C
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126685
[TBL] [Abstract][Full Text] [Related]
39. Value of CT-PET after neoadjuvant chemoradiation in the prediction of histological tumour regression, nodal status and survival in oesophageal adenocarcinoma.
Elliott JA; O'Farrell NJ; King S; Halpenny D; Malik V; Muldoon C; Johnston C; Reynolds JV
Br J Surg; 2014 Dec; 101(13):1702-11. PubMed ID: 25351460
[TBL] [Abstract][Full Text] [Related]
40. Extracellular Flux Assays to Determine Oxidative Phosphorylation and Glycolysis in Chronic Lymphocytic Leukemia Cells.
Vangapandu HV; Gandhi V
Methods Mol Biol; 2019; 1881():121-128. PubMed ID: 30350202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
